Clinical trials: Dyspepsia
Dyspepsia
Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial
Background: Gastric glitch is a new functional disease characterized by severe and transient epigastric pain occurring after challenges such as drinking alcohol and eating specific foods.
- Trial name
- NCT05377619
- Testing
- Prucalopride, Buspirone
- Where
- Brazil
- Volunteers
- 1 people
- Sponsor
- Universidade de Passo Fundo
Functional Dyspepsia
Functional Dyspepsia Microbiome Study
Recurrent abdominal pain has long been acknowledged to be the most common chronic pain entities in children. The purpose of this study is to describe the microbiome in children with FD and to explore relationships between the…
- Trial name
- NCT02340312
- Testing
- EGD, Collection of Stool Specimens
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Children's Mercy Hospital Kansas City
Gastroparesis, Functional Dyspepsia
Controlled Trial of Gastric Electrical Stimulation in Children
This study evaluates whether gastric electrical stimulation (GES) improves symptoms in children with severe nausea and vomiting that have not responded to standard treatments.
- Conditions
- Gastroparesis, Functional Dyspepsia, Vomiting Syndrome
- Trial name
- NCT07474415
- Testing
- Temporary Gastric Electrical Stimulation
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Nationwide Children's Hospital
Dyspepsia Abdominal Burning Pain Diarrhea Dysentery
Concomitant Infection of Intestinal Parasites and Helicobacter Pylori
Intestinal parasitic infections such as Giardia lamblia, Entamoeba histolyica and Enterobius Vermicularis are among the most common infections worldwide.So parasitic infections are considered one of the major health problems in…
- Trial name
- NCT05360940
- Testing
- H.pylori stool antigen rapid test and stool parasitological examination
- Where
- Egypt
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Sohag University
Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD)
Indiana University Gastrointestinal Motility Diagnosis Registry
Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to identify the patients with specific disease conditions.
- Conditions
- Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD), Gastroparesis, Functional Vomiting
- Trial name
- NCT04506593
- Testing
- no intervention
- Where
- United States
- Volunteers
- 5,000 people
- Sponsor
- Indiana University
Gastrointestinal Disorders, Functional
Web-based Management of Pediatric Functional Abdominal Pain
Functional abdominal pain (FAP), a pediatric pain condition without significant organic pathology, is a precursor to chronic pain and high healthcare utilization in young adulthood.
- Trial name
- NCT02327377
- Testing
- Online Cognitive Behavior Therapy, Online Education
- Where
- United States
- Volunteers
- 344 people
- Sponsor
- Vanderbilt University Medical Center
Functional Dyspepsia
Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia
Acid reduction remains the most common treatment prescribed empirically by pediatric gastroenterologists for children with functional dyspepsia (FD).
- Trial name
- Ketotifen (NCT02484248)
- Testing
- Ketotifen
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- Craig A. Friesen, MD
Functional Dyspepsia
Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia
Chronic abdominal pain is the most common persistent pain condition in children and adolescents, affecting 10-15% of children at any given time.
- Trial name
- NCT01373372
- Testing
- Acthrel
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Children's Mercy Hospital Kansas City
Eosinophilia, Dyspepsia
Functional Dyspepsia (FD) - Clinical Response to Montelukast in Children
Duodenal eosinophilia has been associated with dyspepsia in adults and the investigators have previously described the finding of duodenal mucosal eosinophilia in 71-79% of children undergoing diagnostic endoscopy.
- Trial name
- NCT02360696
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Children's Mercy Hospital Kansas City
Functional Abdominal Pain, Irritable Bowel Syndrome
Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain
IND application was submitted to FDA on November 17th.
- Conditions
- Functional Abdominal Pain, Irritable Bowel Syndrome, Functional Dyspepsia
- Trial name
- FAP (NCT01269671)
- Testing
- Melatonin, Peppermint Oil (mentharil), and Simethicone, Sugar pill
- Where
- United States
- Sponsor
- Medical College of Wisconsin
Functional Gastrointestinal Disorders, Abdominal Pain
Internet-delivered CBT for Functional Abdominal Pain in Adolescents - a Pilot
This pilot-study aims to evaluate the treatment effects and feasibility of an internet-delivered CBT-program adjusted for adolescents with functional abdominal pain and functional dyspepsia.
- Conditions
- Functional Gastrointestinal Disorders, Abdominal Pain, Dyspepsia
- Trial name
- NCT02306941
- Testing
- Internet-delivered CBT
- Where
- Sweden
- Volunteers
- 31 people
- Sponsor
- Karolinska Institutet
Functional Gastrointestinal Disorders, Irritable Bowel Syndrome
ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.
This open trial aims to evaluate feasibility and preliminary effectiveness of an internet-delivered CBT-program for children and adolescents with functional gastrointestinal disorders when implemented in regular care.
- Conditions
- Functional Gastrointestinal Disorders, Irritable Bowel Syndrome, Dyspepsia, Functional Abdominal Pain
- Trial name
- NCT03252743
- Testing
- Exposure-based internet-delivered CBT
- Where
- Sweden
- Volunteers
- 68 people
- Sponsor
- Karolinska Institutet
Dyspepsia
Low-value Chronic Prescription of Acid Reducing Medication Among Dutch General Practitioners
Dyspepsia is a commonly encountered clinical condition in Dutch general practice, which is often treated through the prescription of acid-reducing medication (ARM).
- Trial name
- NCT06108817
- Testing
- Information material, No Intervention
- Where
- Netherlands
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Radboud University Medical Center